Amazon Web Services is now accepting purposes for the newest cohort of its Healthcare Accelerator, which this yr will goal bettering well being outcomes for underserved communities.
The accelerator will settle for 10 startups targeted on growing entry to healthcare, decreasing disparities by managing social determinants of well being and utilizing information for fairness in healthcare. The businesses will obtain connections to enterprise capital companies, assist with enterprise planning, AWS coaching, alternatives to work with AWS companions, and go-to-market planning.
That is the second year of AWS’ accelerator within the U.S., and it lately launched a UK-based program that started in March.
Purposes are due July 1, and this system will start in late August.
Anumana, a enterprise from biomedical-data firm nference, introduced it had acquired FDA Breakthrough System Designation for its ECG-based AI algorithm designed for early detection of pulmonary hypertension.
The Breakthrough Device Designation isn’t a advertising and marketing approval from the FDA, but it surely goals to speed up assessment of merchandise that might assist deal with debilitating or life-threatening circumstances.
If the algorithm is accepted sooner or later, Anumana mentioned it may very well be downloaded on a doctor’s gadget, like a smartphone or laptop computer, or accessed on the cloud by an EHR or ECG info administration system.
“Electrophysiology waveforms maintain immense untapped potential for detecting ailments earlier of their pure historical past, significantly for circumstances during which earlier prognosis and therapeutic intervention can delay survival and enhance high quality of life,” Venky Soundararajan, cofounder and chief scientific officer of Anumana and nference, mentioned in an announcement.
“The FDA’s Breakthrough System Designation for Anumana’s PH Early Detection Algorithm is one step ahead for the sphere of ECG AI total, and extra saliently, an enormous leap ahead for PH sufferers.”
AI-enabled imaging corporations Aidoc and Gleamer are partnering to combine the latter’s BoneView device for X-rays into Aidoc’s platform.
Gleamer’s software program earned FDA 510(k) clearance earlier this yr to detect potential fractures from X-rays, sending the outcomes to radiologists for affirmation. In the meantime, Aidoc lately received clearance for its pneumothorax-detection device utilizing X-rays.
“Contemplating that bone trauma X-rays account for a excessive proportion of hospital imaging quantity, the mixing of Gleamer’s resolution is a crucial step in our mission to supply complete protection with AI,” Tom Valent, VP of enterprise improvement at Aidoc, mentioned in an announcement.
“Powered by the enterprise-grade scalability of our AI platform, Gleamer’s resolution is one other extremely valued addition to our suite of industry-leading AI options that, mixed, empower well being methods to enhance affected person outcomes throughout a number of modalities and repair traces inside the hub-and-spoke mannequin.”
